First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical TrialsPeptinovo Biopharma’s Targeted Cancer Drug Platform Moves to Human Trials in Australia
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted ChemotherapyFirst-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary cancer prodrugs
